A breath test could diagnose pneumonia in minutes
Researchers at MIT are developing a portable sensor called PlasmoSniff that detects pneumonia biomarkers in human breath. The system uses inhaled nanoparticles that react to disease-specific enzymes, allowing for rapid, non-invasive diagnosis.
Why it matters
Offers a potential breakthrough in point-of-care diagnostics, reducing the need for expensive lab equipment or radiation-heavy imaging.
Using a portable sensor, the technology analyzes exhaled biomarkers to detect lung conditions without a lab test or chest x-ray.
The article is a scientific report on medical technology development.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in